Delivery Order SPE2DB24D2011-SPE2DB25FBRYE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,298.96 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol used to treat chronic obstructive pulmonary disease. The order, placed on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside designation under firm fixed-price terms. This delivery order represents a child...
- The Defense Logistics Agency awarded a $13,755.65 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol. The order, with an ultimate completion date of June 2, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from...
- The Defense Logistics Agency awarded a delivery order valued at $11,167.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,596.65 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-unit package). This firm fixed-price, non-set-aside contract is set for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,713.43 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol. This firm fixed-price, non-set-aside delivery order was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $27,169.72 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $12,545.61 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $13,390.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination pharmaceutical product used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order,...
- The Defense Logistics Agency awarded a delivery order valued at $27,388.32 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,445.83 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25, a combination respiratory medication delivered in a 60-dose inhaler. Issued on August 25, 2025, with an ultimate completion date of August 26, 2025, this firm fixed price delivery order represents a routine pharmaceutical procurement executed under a competitive, non-set-aside process. The order will be fulfilled from the vendor's Conshohocken,...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRYEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,503.80 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination respiratory medication containing fluticasone propionate, umeclidinium, and vilanterol. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies and medications to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company holds a significant position within the Defense Logistics Agency's Medical Supply Chain, fulfilling diverse pharmaceutical needs ranging from specialty medications to generic drugs and medical devices across multiple therapeutic areas. This delivery order for Trelegy Ellipta reflects the company's ongoing role as a primary vendor supporting military healthcare procurement requirements through the agency's comprehensive pharmaceutical contracting framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/23/25 |